[1]
“Development And In-Vivo Evaluation Of Atorvastatin Solid Lipid Nanoparticles For Anti-Hyperlipidemic Activity”, JOC, vol. 24, no. 8s, pp. 343–351, Oct. 2025, doi: 10.64149/J.Carcinog.24.8s.343-351.